MedPath

Effects of age on the optimal effect-site concentration of remifentanil for preventing cough during anesthetic emergence in male patients undergoing laparoscopic cholecystectomy

Not Applicable
Recruiting
Conditions
Not Applicable
Registration Number
KCT0002353
Lead Sponsor
Ajou University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
50
Inclusion Criteria

Male patients (20-50 yrs or 65-75yrs) with American Society Anesthesiologist (ASA) physical status I or II undergoing laparoscopic cholecystectomy will be enrolled in this study.

Exclusion Criteria

Patients with predicted difficult airway, body mass index > 30 kg/m2, history of upper respiratory infection or respiratory disease, current smokers, uncontrolled hypertension or diabetes, moderate to severe coronary artery disease wilil be excluded from the study.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
presence or absence of cough after extubation within 5 min
Secondary Outcome Measures
NameTimeMethod
presence or absence of cough after extubation, changes of blood pressure, HR within 5 min of extubation
© Copyright 2025. All Rights Reserved by MedPath